Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 88,143 |
| Marketable Securities | 0 | 0 | 55,338 |
| Receivables | 0 | 0 | 303 |
| Other current assets | 0 | 0 | 3,424 |
| TOTAL | $0 | $0 | $147,208 |
| Non-Current Assets | |||
| Other Non-Current Assets | 0 | 0 | 33 |
| TOTAL | $N/A | $N/A | $33 |
| Total Assets | $0 | $0 | $147,747 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 0 | 0 | 8,966 |
| Accounts payable and accrued liabilities | 0 | 0 | 985 |
| Accrued Expenses | 0 | 0 | 5,289 |
| TOTAL | $0 | $0 | $15,429 |
| Non-Current Liabilities | |||
| Long Term Debt | 0 | 0 | 6,532 |
| Other Non-Current Liabilities | 0 | 0 | 203,222 |
| TOTAL | $N/A | $N/A | $209,754 |
| Total Liabilities | $0 | $0 | $225,440 |
| Shareholders' Equity | |||
| Retained earnings | 0 | 0 | -81,335 |
| TOTAL | $0 | $0 | $-77,693 |
| Total Liabilities And Equity | $0 | $0 | $147,747 |